What is ZoomMed?
ZoomMed operates at the intersection of clinical practice and pharmacy management, offering a suite of innovative healthcare software solutions. Its flagship product, the ZRx Prescriber, serves as a predictive e-prescribing tool that empowers physicians to streamline their practice through data-driven insights. Complementing this, the company provides PraxisLab, a specialized platform engineered for the unique operational requirements of pharmacy chains. By securing distribution rights for advanced tools like Rx Vigilance's Quick Glance, ZoomMed has effectively positioned itself as a critical infrastructure provider for EHR vendors, pharmacists, and medical practitioners seeking to enhance operational efficiency and patient safety.
How much funding has ZoomMed raised?
ZoomMed has raised a total of $500K across 1 funding round:
Debt
$500K
Debt (2017): $500K, investors not publicly disclosed
Key Investors in ZoomMed
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ZoomMed?
With this major enterprise-level funding, ZoomMed is well-positioned to scale its software distribution and deepen its integration within the existing healthcare ecosystem. The strategic focus will likely shift toward expanding the footprint of the ZRx Prescriber and PraxisLab platforms, potentially through enhanced interoperability with major EHR systems. As the company matures, the emphasis will remain on leveraging its predictive capabilities to reduce administrative burdens for clinicians, thereby driving long-term value for its stakeholders and improving the standard of care across its network of pharmacy and physician partners.
See full ZoomMed company page
